Causaly and Syneos Health Partner to Raise the Scientific Intensity of Clinical Research
August 18, 2026
Collaboration embeds evidence-grounded agentic AI into scientific workflows across Syneos Health, accelerating research while strengthening scientific rigor, consistency, and sponsor value LONDON -- Causaly, the agentic AI platform purpose-built for life sciences research and development, today announced a strategic partnership with Syneos Health, a leading fully integrated biopharmaceutical solutions organization. The collaboration will help establish a [...]
Anders Fogelberg appointed President and CEO of BICO Group AB
August 18, 2026
The Board of Directors of BICO Group AB today announces the appointment of Anders Fogelberg, currently Chief Commercial Officer, as President and CEO, effective September 1, 2026. The Board of Directors have, in a constructive dialogue together with the current President and CEO, Maria Forss, concluded that the time is right for a leadership change. [...]
Xylem Appoints Andrea van der Berg Chief Financial Officer
August 18, 2026
WASHINGTON -- Xylem Inc. (NYSE: XYL), a leading global water solutions company, today announced that Andrea van der Berg has been appointed Executive Vice President and Chief Financial Officer, effective September 1, 2026. She will report to President and Chief Executive Officer Matthew Pine and join Xylem’s Executive Leadership Team. Van der Berg succeeds William [...]
August 18, 2026
Uppsala, Sweden – Navinci Diagnostics AB today announces that the company has initiated a collaboration with BrainZell to explore the use of Navinci’s in situ Proximity Ligation Assay technology in human brain organoid models to support relevant studies of biology and drug response. The collaboration aims to evaluate how functional spatial readouts can be applied [...]
Stanhope-Seta Expands UKAS ISO 17034 Accredited Certified Reference Material Range
August 18, 2026
Laboratories rely on accurate, repeatable and traceable test results to support product quality, regulatory compliance and operational safety. Routine verification of laboratory instruments plays a vital role in maintaining confidence in those results. Stanhope-Seta is pleased to announce the expansion of its UKAS ISO 17034 accreditation, with the addition of five new Certified Reference Materials (CRMs) [...]
August 17, 2026
Purpose-engineered cell-like controls deliver improved positive/negative separation, broad species compatibility, and a liquid, non-biohazardous ready-to-use format EMERYVILLE, Calif. -- Slingshot Bio, Inc., a leader in precision cell mimic controls for flow cytometry, today announced the commercial launch of ViaComp® Ultra Amine, a next-generation compensation control designed for amine-reactive viability dyes and fluorophore-conjugated antibody panels in [...]
28bio Launches CNS-3D Plasticity Organoids to Assess Drug Effects on Human Learning and Memory
August 17, 2026
Cognitive biomarker assays inform safety and efficacy decisions by measuring network potentiation and synaptic plasticity Advances the emerging field of organoid intelligence for drug development applications NEW ORLEANS -- 28bio today launched CNS-3D Plasticity Organoids, enabling human functional endpoints of learning and memory before drug candidates enter clinical testing. Attrition in neurodegeneration remains among the highest [...]
August 17, 2026
New handheld spectrophotometer will be showcased with digital color workflow solutions at LOUPE Americas and PRINTING United Expo. GRAND RAPIDS, Mich. -- X-Rite Pantone, the global authority in color standards and color science, announces eXact™ 2 Basic, the newest addition to the eXact 2 family of portable spectrophotometers. Available now, the new device will be showcased [...]
August 14, 2026
Milestone release introduces L7|SYNAPSE™ AI framework, up to 100x performance boost, and advanced NORs & PARs compliance modeling to power mission-critical operations. AUSTIN, Texas — L7 Informatics, Inc., a provider of foundational data orchestration and digital transformation infrastructure for precision sciences, today announced the general availability of L7|ESP 2026.1. Building on a unified composable data [...]
August 13, 2026
Introducing a new AI approach for accelerated biomarker discovery, demonstrated through Alzheimer’s disease biomarker modeling validated in an independent cohort Basel, Switzerland -- Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new AI agent in Genedata Profiler®, its enterprise platform for integrating and analyzing data across [...]

